ClinicalTrials.Veeva

Menu

An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy

U

University of Catania

Status

Completed

Conditions

Purtscher Retinopathy
Pancreatic Cancer

Treatments

Drug: Methylprednisolone

Study type

Observational

Funder types

Other

Identifiers

NCT05350384
UCatania666

Details and patient eligibility

About

AN UNUSUAL ASSOCIATION BETWEEN PANCREATIC CANCER AND PURTSCHER-LIKE RETINOPATHY

Full description

Purtscher's retinopathy may cause sudden loss of vision of varying severity, secondary to head or chest injury. Its pathophysiology is unclear. Purtscher's-like retinopathy has more attenuated clinical and objective features and can be associated with many non-neoplastic pathologies.

Otherwise, an association of this kind of retinopathy with malignancies has been described once in the Literature (multiple myeloma). We present a case report on a unique association between pancreatic cancer and Purtscher-type retinopathy.

Enrollment

1 patient

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: NONE -

Exclusion Criteria: NONE

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems